文献速递消化道肿瘤放疗胸部肿瘤放疗

放疗范围与剂量对新辅助放化疗后食管切除胃管颈部吻合并发症的影响

Influence of the Extent and Dose of Radiation on Complications After Neoadjuvant Chemoradiation and Subsequent Esophagectomy With Gastric Tube Reconstruction With a Cervical Anastomosis.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-12-14

本研究纳入2005至2012年364例接受新辅助放化疗(41.4 Gy联合化疗)后行食管切除胃管颈部吻合的食管癌患者,分析胃底未来吻合区及纵隔的放疗范围与剂量对吻合口并发症的影响。结果显示吻合口漏发生率为22%、吻合口狭窄为41%,胃底平均剂量24.2 Gy及V20-V40等剂量参数与吻合口漏或狭窄均无关联;严重并发症(Clavien-Dindo≥IIIB)发生率为28%,多发合并症和纵隔比值0.5-1.0是其独立预测因素。

要点

  • 胃底未来吻合区平均剂量24.2 Gy时,放疗剂量与吻合口漏或狭窄发生率无关。
  • 吻合口漏发生率为22%,吻合口狭窄发生率为41%。
  • 纵隔比值0.5-1.0和多发合并症是严重并发症的独立预测因素。

核心结论

  • 胃底未来吻合区平均放疗剂量24.2 Gy时,放疗剂量与吻合口漏或吻合口狭窄的发生率无关。
  • 严重并发症的发生与上纵隔计划靶区边界较高相关。

研究设计与样本

  • 2005至2012年连续纳入364例食管癌患者,均接受新辅助放化疗(41.4 Gy联合化疗)后行食管切除术。
  • 确定胃底未来吻合区,计算平均剂量、V20-V40及上纵隔计划靶区边界与纵隔长度的比值(纵隔比值)。

主要发现

  • 吻合口漏发生率为22%,吻合口狭窄发生率为41%。
  • 逻辑回归分析显示年龄、合并症、胃底平均剂量、V20-V40或纵隔比值对吻合口漏或吻合口狭窄发生率均无影响。
  • 28%的患者发生严重并发症(Clavien-Dindo评分≥IIIB)。

关键数值与推荐

  • 胃底未来吻合区平均放疗剂量为24.2 Gy。
  • 吻合口漏发生率为22%,吻合口狭窄发生率为41%。
  • 严重并发症(Clavien-Dindo评分≥IIIB)发生率为28%。

临床怎么用

  • 胃底未来吻合区平均剂量24.2 Gy时,无需因担忧吻合口漏或狭窄而限制该区域放疗剂量。
  • 对于有多发合并症或纵隔比值0.5-1.0的患者,应警惕严重并发症风险并加强围手术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine, in a large series, the influence of the extent and dose of radiation to the fundus of the stomach and mediastinum on the development and severity of anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation followed by esophagectomy with cervical anastomosis. METHODS AND MATERIALS: Between 2005 and 2012, 364 consecutive patients with esophageal cancer treated with neoadjuvant chemoradiation (41.4 Gy combined with chemotherapy) followed by esophagectomy were included. The future anastomotic region in the fundus was determined, and the mean dose, V20-V40, and upper planning target volume border in relation to mediastinal length, expressed as the mediastinal ratio, were calculated. RESULTS: Anastomotic leakage occurred in 22% and anastomotic stenosis in 41%. Logistic regression analysis revealed no influence of age, comorbidity, mean fundus dose, V20-V40, or the mediastinal ratio on the incidence of anastomotic leakage or anastomotic stenosis. In 28% of the patients severe complications (Clavien-Dindo score of ≥IIIB) occurred. The presence of multiple comorbidities (hazard ratio 2.4 [95% confidence interval 1.3-4.5], P=.006) and a mediastinal ratio of 0.5 to 1.0 (hazard ratio 1.9 [95% confidence interval 1.0-3.5], P=.036) were both independent predictors of severe complications. CONCLUSION: With a mean radiation dose of 24.2 Gy to the future anastomotic region of the gastric fundus, the radiation dose was not associated with the incidence of anastomotic leakage or anastomotic stenosis. The incidence of severe complications was associated with a high superior mediastinal planning target volume border.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Koëter M, Kathiravetpillai N, Gooszen JA, et al. Influence of the Extent and Dose of Radiation on Complications After Neoadjuvant Chemoradiation and Subsequent Esophagectomy With Gastric Tube Reconstruction With a Cervical Anastomosis. Int J Radiat Oncol Biol Phys. 2016. PMID: 28244418. doi:10.1016/j.ijrobp.2016.11.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。